Disruption of cytokeratin-8 interaction with F508del-CFTR corrects its functional defect

Julien Colas, Grazyna Faure, Emilie Saussereau, Stéphanie Trudel, Wael Rabeh, Sara Bitam, Ida Chiara Guerrera, Janine Fritsch, Isabelle Sermet-gaudelus, Noëlie Davezac, Franck Brouillard, Gergely L. Lukacs, Harald Herrmann, Mario Ollero, Aleksander Edelman

Research output: Contribution to journalArticle

Abstract

We have previously reported an increased expression of cytokeratins 8/18 (K8/K18) in cells expressing the F508del mutation of cystic fibrosis transmembrane conductance regulator (CFTR). This is associated with increased colocalization of CFTR and K18 in the vicinity of the endoplasmic reticulum, although this is reversed by treating cells with curcumin, resulting in the rescue of F508del-CFTR. In the present work, we hypothesized that (i) the K8/K18 network may interact physically with CFTR, and that (ii) this interaction may modify CFTR function. CFTR was immunoprecipitated from HeLa cells transfected with either wild-type (WT) CFTR or F508del-CFTR. Precipitates were subjected to 2D-gel electrophoresis and differential spots identified by mass spectrometry. K8 and K18 were found significantly increased in F508del-CFTR precipitates. Using surface plasmon resonance, we demonstrate that K8, but not K18, binds directly and preferentially to the F508del over the WT human NBD1 (nucleotide-binding domain-1). In vivo K8 interaction with F508del-CFTR was confirmed by proximity ligation assay in HeLa cells and in primary cultures of human respiratory epithelial cells. Ablation of K8 expression by siRNA in F508del-expressing HeLa cells led to the recovery of CFTR-dependent iodide efflux. Moreover, F508del-expressing mice topically treated with K8-siRNA showed restored nasal potential difference, equivalent to that of WT mice. These results show that disruption of F508del-CFTR and K8 interaction leads to the correction of the F508del-CFTR processing defect, suggesting a novel potential therapeutic target in CF.

Original languageEnglish (US)
Article numberddr496
Pages (from-to)623-634
Number of pages12
JournalHuman Molecular Genetics
Volume21
Issue number3
DOIs
StatePublished - Feb 1 2012

Fingerprint

Keratin-8
Cystic Fibrosis Transmembrane Conductance Regulator
HeLa Cells
Small Interfering RNA
Keratin-18
Curcumin
Surface Plasmon Resonance
Electrophoresis, Gel, Two-Dimensional
Iodides
Nose
Endoplasmic Reticulum

ASJC Scopus subject areas

  • Molecular Biology
  • Genetics
  • Genetics(clinical)

Cite this

Colas, J., Faure, G., Saussereau, E., Trudel, S., Rabeh, W., Bitam, S., ... Edelman, A. (2012). Disruption of cytokeratin-8 interaction with F508del-CFTR corrects its functional defect. Human Molecular Genetics, 21(3), 623-634. [ddr496]. https://doi.org/10.1093/hmg/ddr496

Disruption of cytokeratin-8 interaction with F508del-CFTR corrects its functional defect. / Colas, Julien; Faure, Grazyna; Saussereau, Emilie; Trudel, Stéphanie; Rabeh, Wael; Bitam, Sara; Guerrera, Ida Chiara; Fritsch, Janine; Sermet-gaudelus, Isabelle; Davezac, Noëlie; Brouillard, Franck; Lukacs, Gergely L.; Herrmann, Harald; Ollero, Mario; Edelman, Aleksander.

In: Human Molecular Genetics, Vol. 21, No. 3, ddr496, 01.02.2012, p. 623-634.

Research output: Contribution to journalArticle

Colas, J, Faure, G, Saussereau, E, Trudel, S, Rabeh, W, Bitam, S, Guerrera, IC, Fritsch, J, Sermet-gaudelus, I, Davezac, N, Brouillard, F, Lukacs, GL, Herrmann, H, Ollero, M & Edelman, A 2012, 'Disruption of cytokeratin-8 interaction with F508del-CFTR corrects its functional defect', Human Molecular Genetics, vol. 21, no. 3, ddr496, pp. 623-634. https://doi.org/10.1093/hmg/ddr496
Colas, Julien ; Faure, Grazyna ; Saussereau, Emilie ; Trudel, Stéphanie ; Rabeh, Wael ; Bitam, Sara ; Guerrera, Ida Chiara ; Fritsch, Janine ; Sermet-gaudelus, Isabelle ; Davezac, Noëlie ; Brouillard, Franck ; Lukacs, Gergely L. ; Herrmann, Harald ; Ollero, Mario ; Edelman, Aleksander. / Disruption of cytokeratin-8 interaction with F508del-CFTR corrects its functional defect. In: Human Molecular Genetics. 2012 ; Vol. 21, No. 3. pp. 623-634.
@article{7cda56429d0747eba82d84ac0115e939,
title = "Disruption of cytokeratin-8 interaction with F508del-CFTR corrects its functional defect",
abstract = "We have previously reported an increased expression of cytokeratins 8/18 (K8/K18) in cells expressing the F508del mutation of cystic fibrosis transmembrane conductance regulator (CFTR). This is associated with increased colocalization of CFTR and K18 in the vicinity of the endoplasmic reticulum, although this is reversed by treating cells with curcumin, resulting in the rescue of F508del-CFTR. In the present work, we hypothesized that (i) the K8/K18 network may interact physically with CFTR, and that (ii) this interaction may modify CFTR function. CFTR was immunoprecipitated from HeLa cells transfected with either wild-type (WT) CFTR or F508del-CFTR. Precipitates were subjected to 2D-gel electrophoresis and differential spots identified by mass spectrometry. K8 and K18 were found significantly increased in F508del-CFTR precipitates. Using surface plasmon resonance, we demonstrate that K8, but not K18, binds directly and preferentially to the F508del over the WT human NBD1 (nucleotide-binding domain-1). In vivo K8 interaction with F508del-CFTR was confirmed by proximity ligation assay in HeLa cells and in primary cultures of human respiratory epithelial cells. Ablation of K8 expression by siRNA in F508del-expressing HeLa cells led to the recovery of CFTR-dependent iodide efflux. Moreover, F508del-expressing mice topically treated with K8-siRNA showed restored nasal potential difference, equivalent to that of WT mice. These results show that disruption of F508del-CFTR and K8 interaction leads to the correction of the F508del-CFTR processing defect, suggesting a novel potential therapeutic target in CF.",
author = "Julien Colas and Grazyna Faure and Emilie Saussereau and St{\'e}phanie Trudel and Wael Rabeh and Sara Bitam and Guerrera, {Ida Chiara} and Janine Fritsch and Isabelle Sermet-gaudelus and No{\"e}lie Davezac and Franck Brouillard and Lukacs, {Gergely L.} and Harald Herrmann and Mario Ollero and Aleksander Edelman",
year = "2012",
month = "2",
day = "1",
doi = "10.1093/hmg/ddr496",
language = "English (US)",
volume = "21",
pages = "623--634",
journal = "Human Molecular Genetics",
issn = "0964-6906",
publisher = "Oxford University Press",
number = "3",

}

TY - JOUR

T1 - Disruption of cytokeratin-8 interaction with F508del-CFTR corrects its functional defect

AU - Colas, Julien

AU - Faure, Grazyna

AU - Saussereau, Emilie

AU - Trudel, Stéphanie

AU - Rabeh, Wael

AU - Bitam, Sara

AU - Guerrera, Ida Chiara

AU - Fritsch, Janine

AU - Sermet-gaudelus, Isabelle

AU - Davezac, Noëlie

AU - Brouillard, Franck

AU - Lukacs, Gergely L.

AU - Herrmann, Harald

AU - Ollero, Mario

AU - Edelman, Aleksander

PY - 2012/2/1

Y1 - 2012/2/1

N2 - We have previously reported an increased expression of cytokeratins 8/18 (K8/K18) in cells expressing the F508del mutation of cystic fibrosis transmembrane conductance regulator (CFTR). This is associated with increased colocalization of CFTR and K18 in the vicinity of the endoplasmic reticulum, although this is reversed by treating cells with curcumin, resulting in the rescue of F508del-CFTR. In the present work, we hypothesized that (i) the K8/K18 network may interact physically with CFTR, and that (ii) this interaction may modify CFTR function. CFTR was immunoprecipitated from HeLa cells transfected with either wild-type (WT) CFTR or F508del-CFTR. Precipitates were subjected to 2D-gel electrophoresis and differential spots identified by mass spectrometry. K8 and K18 were found significantly increased in F508del-CFTR precipitates. Using surface plasmon resonance, we demonstrate that K8, but not K18, binds directly and preferentially to the F508del over the WT human NBD1 (nucleotide-binding domain-1). In vivo K8 interaction with F508del-CFTR was confirmed by proximity ligation assay in HeLa cells and in primary cultures of human respiratory epithelial cells. Ablation of K8 expression by siRNA in F508del-expressing HeLa cells led to the recovery of CFTR-dependent iodide efflux. Moreover, F508del-expressing mice topically treated with K8-siRNA showed restored nasal potential difference, equivalent to that of WT mice. These results show that disruption of F508del-CFTR and K8 interaction leads to the correction of the F508del-CFTR processing defect, suggesting a novel potential therapeutic target in CF.

AB - We have previously reported an increased expression of cytokeratins 8/18 (K8/K18) in cells expressing the F508del mutation of cystic fibrosis transmembrane conductance regulator (CFTR). This is associated with increased colocalization of CFTR and K18 in the vicinity of the endoplasmic reticulum, although this is reversed by treating cells with curcumin, resulting in the rescue of F508del-CFTR. In the present work, we hypothesized that (i) the K8/K18 network may interact physically with CFTR, and that (ii) this interaction may modify CFTR function. CFTR was immunoprecipitated from HeLa cells transfected with either wild-type (WT) CFTR or F508del-CFTR. Precipitates were subjected to 2D-gel electrophoresis and differential spots identified by mass spectrometry. K8 and K18 were found significantly increased in F508del-CFTR precipitates. Using surface plasmon resonance, we demonstrate that K8, but not K18, binds directly and preferentially to the F508del over the WT human NBD1 (nucleotide-binding domain-1). In vivo K8 interaction with F508del-CFTR was confirmed by proximity ligation assay in HeLa cells and in primary cultures of human respiratory epithelial cells. Ablation of K8 expression by siRNA in F508del-expressing HeLa cells led to the recovery of CFTR-dependent iodide efflux. Moreover, F508del-expressing mice topically treated with K8-siRNA showed restored nasal potential difference, equivalent to that of WT mice. These results show that disruption of F508del-CFTR and K8 interaction leads to the correction of the F508del-CFTR processing defect, suggesting a novel potential therapeutic target in CF.

UR - http://www.scopus.com/inward/record.url?scp=84856096159&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84856096159&partnerID=8YFLogxK

U2 - 10.1093/hmg/ddr496

DO - 10.1093/hmg/ddr496

M3 - Article

C2 - 22038833

AN - SCOPUS:84856096159

VL - 21

SP - 623

EP - 634

JO - Human Molecular Genetics

JF - Human Molecular Genetics

SN - 0964-6906

IS - 3

M1 - ddr496

ER -